The purpose of this guideline is to assist manufacturers of
blood and blood components, including blood banks, transfusion
services, and plasmapheresis centers, in developing a quality
assurance (QA) program in their effort to be consistent with
recognized principles of quality assurance and current good
manufacturing practice (CGMP).